These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2711436)

  • 1. Improved cardioplegia using new perfusates.
    Wicomb WN; Collins GM; Wood J; Hill JD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1357-8. PubMed ID: 2711436
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced myocardial viability with hypothermic storage in Euro-Collins solution.
    Dzielak DJ; Raju S; Woolley S
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1364-5. PubMed ID: 2652449
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation.
    Rousou JA; Engelman RM; Breyer RH; Otani H; Lemeshow S; Das DK
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):625-30. PubMed ID: 3352296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of cardiac preservation with Celsior or University of Wisconsin solution with or without prior administration of cardioplegia.
    Boku N; Tanoue Y; Kajihara N; Eto M; Masuda M; Morita S
    J Heart Lung Transplant; 2006 Feb; 25(2):219-25. PubMed ID: 16446224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen requirements of the isolated rat heart during hypothermic cardioplegia. Effect of oxygenation on metabolic and functional recovery after five hours of arrest.
    de Wit L; Coetzee A; Kotze J; Lochner A
    J Thorac Cardiovasc Surg; 1988 Feb; 95(2):310-20. PubMed ID: 3339898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immature and the mature myocardium. Responses to multidose crystalloid cardioplegia.
    Magovern JA; Pae WE; Miller CA; Waldhausen JA
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):618-24. PubMed ID: 3352295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-dose crystalloid cardioplegia preserves intracellular sodium homeostasis in myocardium.
    Schepkin VD; Choy IO; Budinger TF; Young JN; DeCampli WM
    J Mol Cell Cardiol; 1999 Sep; 31(9):1643-51. PubMed ID: 10471348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of polyethylene glycol (PEG) and horseradish peroxidase (HRP) for hypothermic rabbit heart perfusion.
    Wicomb WN; Wood J; Hill JD; Bry WI; Collins GM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1366-8. PubMed ID: 2711437
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there any effect of methylprednisolone in cardioplegic solution on myocardial protection?
    Tsai CH; Hsu CH; Mai LM; Wang SS; Chu SH
    Taiwan Yi Xue Hui Za Zhi; 1988 Jan; 87(1):49-54. PubMed ID: 3361292
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of cardioplegic and UW solutions for short-term rabbit heart preservation.
    Wicomb WN; Hill JD; Avery J; Collins GM
    Transplantation; 1989 Apr; 47(4):733-4. PubMed ID: 2650055
    [No Abstract]   [Full Text] [Related]  

  • 11. Direct assessment of the antioxidant effects of a new heart preservation solution, Celsior. A hemodynamic and electron spin resonance study.
    Pietri S; Culcasi M; Albat B; Albérici G; Menasché P
    Transplantation; 1994 Sep; 58(6):739-42. PubMed ID: 7940702
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of myocardial metabolism with microdialysis after protection with cold blood- or cold crystalloid cardioplegia. A porcine model.
    Runge M; Hughes P; Peter Gøtze J; Petersen RH; Steinbrüchel DA
    Scand Cardiovasc J; 2006 Jun; 40(3):186-93. PubMed ID: 16798667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improved protection of hypertrophied myocardium in ischemia by histidine buffer cardioplegia].
    Takeuchi K; Takashima K; Suzuki S; Fukui K; del Nido PJ
    Kyobu Geka; 1995 Jun; 48(6):461-3. PubMed ID: 7602857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calcium requirement for hypothermic storage of the cardiac explant.
    Batty PR; Hicks GL; De Weese JA; Wang TC
    Curr Surg; 1989; 46(4):313-6. PubMed ID: 2670457
    [No Abstract]   [Full Text] [Related]  

  • 15. Preclinical evaluation of coronary vascular function after cardioplegia with HTK and different antioxidant additives.
    Schröder C; Heintz A; Pexa A; Rauen U; Deussen A
    Eur J Cardiothorac Surg; 2007 May; 31(5):821-6. PubMed ID: 17321142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular indices of apoptosis after intermittent blood and crystalloid cardioplegia.
    Feng J; Bianchi C; Sandmeyer JL; Li J; Sellke FW
    Circulation; 2005 Aug; 112(9 Suppl):I184-9. PubMed ID: 16159813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial protection in the failing heart: II. Effect of pulsatile cardioplegic perfusion under simulated left ventricular restoration.
    Kassab GS; Kostelec M; Buckberg GD; Covell J; Sadeghi A; Hoffman JI
    J Thorac Cardiovasc Surg; 2006 Oct; 132(4):884-90. PubMed ID: 17000301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial ischemia-reperfusion injury of the transplanted rat heart: improved protection by preservation versus cardioplegic solutions.
    Schneeberger S; Kuznetsov AV; Seiler R; Renz O; Meusburger H; Mark W; Brandacher G; Margreiter R; Gnaiger E
    Shock; 2008 Oct; 30(4):365-71. PubMed ID: 18317412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor blood perfusion improves myocardial recovery after heart transplantation.
    Rao V; Feindel CM; Weisel RD; Boylen P; Cohen G
    J Heart Lung Transplant; 1997 Jun; 16(6):667-73. PubMed ID: 9229297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of myocardial high-energy phosphates during cardioplegic arrest with nifedipine.
    Kadowaki MH; Levett JM; Ip JH; Karp RB
    Curr Surg; 1987; 44(4):298-9. PubMed ID: 3665578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.